Cargando…
Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract
The COVID-19 pandemic has currently created an unprecedented threat to human society and global health. A rapid mass vaccination to create herd immunity against SARS-CoV-2 is a crucial measure to ease the spread of this disease. Here, we investigated the immunogenicity of a SARS-CoV-2 subunit vaccin...
Autores principales: | Jearanaiwitayakul, Tuksin, Apichirapokey, Suttikarn, Chawengkirttikul, Runglawan, Limthongkul, Jitra, Seesen, Mathurin, Jakaew, Phissinee, Trisiriwanich, Sakalin, Sapsutthipas, Sompong, Sunintaboon, Panya, Ubol, Sukathida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617950/ https://www.ncbi.nlm.nih.gov/pubmed/34835008 http://dx.doi.org/10.3390/v13112202 |
Ejemplares similares
-
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022) -
The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2023) -
Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination
por: Nantachit, Nattika, et al.
Publicado: (2016) -
Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study
por: Rungrojcharoenkit, Kamonthip, et al.
Publicado: (2020)